Background: The Maze procedure in patients without mitral valve disease remains controversial, because of the increased invasiveness and operation time required to create additional incisions in the atria. The ain of this study was to assess prognosis following the Maze procedure in patients without mitral valve disease. Methods and Results: One hundred and seven consecutive patients who underwent the Maze procedure between 2002 and 2008 was enrolled in this study. Patients were divided into two groups based on the presence or absence of mitral valve disease. Freedom from atrial fibrillation was compared by multivariate logistic regression analysis at discharge. The KaplanMeier method and Cox-proportional hazard analysis adjusted for other predictors were estimated to compare freedom from atrial fibrillation at follow-up. Follow-up was 98% complete and mean duration of follow-up was 457 days. Operation and aorta cross-clamp times were similar between groups. No differences were identified in freedom from atrial fibrillation at discharge (non-mitral valve surgery, 55% vs. mitral valve surgery, 66%) or follow-up (57% vs. 61%, respectively). In multivariate Cox proportional hazard modelling, the presence of mitral valve disease was not associated with a poor success rate of conversion. Conclusions: Results of the Maze procedure for atrial fibrillation without mitral valve disease were acceptable. The Maze procedure could be a beneficial option for these patients to avoid adverse events of atrial fibrillation.
Introduction
Atrial fibrillation (AF) is a frequent cardiac arrhythmia in patients undergoing mitral valve surgery. 1) Several reports have demonstrated that AF can be treated suitably with the Cox-Maze procedure, achieving postoperative freedom from AF. 2) Furthermore, the prevalence of late stroke is significantly decreased in patients undergoing the Cox-Maze procedure, in addition to mitral valve procedures.
3) AF sometimes coexists with non-mitral valve disease and can cause several adverse events, including thromboembolism or haemorrhage related to anticoagulant therapy 4, 5) However, use of the Cox-Maze procedure in patients with non-mitral valve disease remains controversial because of the additional invasiveness of ablation. The aim of this study was to assess the adequacy of the Maze procedure in patients with nonmitral valvular AF.
Methods

Patients
Preoperative data from patients who underwent the Maze procedure at Juntendo University Hospital between November 2002 and April 2008 were entered into an institutional structured database. All patients agreed to the use of their information for clinical research, and written informed consent was obtained prior to surgical treatment. This study was performed according to the ethics policies of the institution. Demographic data (including age, gender, and body mass index), blood pressure on admission, fasting levels of plasma glucose, medication use, operative parameters, and laboratory investigations (including electrocardiography and echocardiography) were prospectively recorded. The indication of the Maze procedure enrolled all patients who had AF of every description. Persistent AF was defined as continuous AF over 3 months before the operation, and it was not self-terminating. There was no specific exclusion criterion in our institution. Three in-hospital deaths occurred, due to methicillin-resistant Staphylococcus aureus sepsis in one patient and low output syndrome in two patients. The three patients who died in hospital were excluded from the study.
Diabetes mellitus was defined as fasting plasma glucose level ≥ 126 mg/dL or a requirement for treatment with oral hypoglycaemic medication or insulin. Hypertension was defined as systolic blood pressure ≥ 140 mmHg, diastolic blood pressure ≥ 90 mmHg, or a requirement for treatment with specific antihypertensive medications. Chronic kidney disease was defined as glomerular filtration rate < 60 mL/min/1.73 m 2 , as calculated by the Modification of Diet in Renal Disease equation, without dialysis treatment. Persistent AF is defined as AF which is sustained beyond seven days, or lasting less than seven days but necessitating pharmacologic or electrical cardioversion. In addition, AF was detected by self-screening of pulse by patients and all patients had been trained to make self-screening of the pulse for AF before discharge.
6, 7)
Outcomes
Incidences of outcomes were obtained from our institutional structured database. Outcomes assessed in this study were operation time, aorta cross clamp time, and freedom from AF. Follow-up data were collected from medical records of outpatient visits and correspondence with referring physicians. Remote freedom from AF was determined by electrocardiography. According to periodic electrocardiography at each outpatient visits, Holter ECG was used to confirm AF when patients identified an irregular pulse, palpitation, or chest discomfort.
Surgical procedure
All Maze procedures were performed under conventional cardiopulmonary bypass with blood cardioplegic solution, normothermia (36-37°C), and cardioplegic arrest. All patients underwent the Kosakai Maze procedure, 2) left atrial Maze procedure or Cox-Maze IV procedure. 8) In the Cox-Maze IV procedure, cryolesions at the mitral and tricuspid annulus were replaced by radiofrequency ablation. Cardioblate (Medtronic, Minneapolis, MN) and AtriCure (AtriCure Inc. West Chester, OH) were applied for radiofrequency ablation. With respect to the left atrial appendage (LAA), either resection or ligation was performed. Left atrial Maze procedure was based on the simple left atrial procedure 9) or Cox-Maze IV without a right atrial lesion set.
Statistical analysis
To compare patient characteristics, categorical data were tabulated as frequency and percentage, and continuous variables were expressed as mean ± standard deviation. Data were analysed using the χ 2 test or Mann-Whitney U test. The impact of the Maze procedure without mitral valve surgery at discharge was calculated by multivariate logistic regression analysis, adjusting for established predictors included left atrial diameter (LAD), left ventricular ejection fraction and age. [10] [11] [12] Freedom from AF was estimated using the Kaplan-Meier survival method and compared with a log-rank test. Furthermore, multivariate Cox proportional-hazard analyses were performed to calculate adjusted hazard ratios between groups. Values of P < 0.05 were considered to indicate an independent risk factor and all reported P-values were two-tailed. All statistical analyses were performed using SPSS for Windows version 16.0 software (SPSS, Chicago, IL).
Results
Patient characteristics
The 107 consecutive patients who underwent the Maze procedure comprised 11 patients with non-mitral valve surgery and 96 patients with mitral valve surgery. A comparison of baseline characteristics between groups is shown in Table 1 .
Mean age of the study population was 63 years. 
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Outcomes
Baseline characteristics and operative parameters are shown in Fig. 1 . A total of 107 patients included 11 patients without mitral valve surgery and 96 patients with mitral valve surgery were enrolled in this study. The LAD in patients with mitral valve surgery was significantly higher than in patients without mitral valve surgery (45 ± 5.7mm vs. 54 ± 8.6mm, P = 0.0023). Patients without mitral valve surgery were more likely to include older patients (70 ± 8.1 vs. 62 ± 13, P = 0.07). None of the other variables significantly differed between the two groups. As for operative parameters, no significant differences in operation time (non-mitral valve surgery, 381 min vs. mitral valve surgery, 388 min) or aorta crossclamp time (167 vs. 166 min, respectively) were observed between the two groups ( Table 2) .
Follow-up was 98% completed and mean follow-up period was 457 ± 404 days. Five patients in the mitral valve surgery group needed insertion of a pacemaker for bradycardia during follow-up. One perioperative stroke occurred in the non-mitral valve group. Four patients died in the follow-up period: in the mitral valve surgery group, one patient died of cancer and another died from cerebral haemorrhage; in the non-mitral valve surgery group, one patient died from congestive heart failure and another experienced sudden death.
At discharge, rates of freedom from AF were 55% in the non-mitral valve surgery group and 66% in the mitral valve surgery group (P = 0.50). Results of multivariate logistic modelling adjusted for LAD, left ventricular ejection fraction, and age are shown in Table 3 . Presence of mitral valve surgery was not associated with a sinus conversion rate at discharge. The only independent predictor of an unsuccessful sinus conversion at discharge was an increased LAD.
Cumulative rates of freedom from AF curves grouped by the presence of mitral valve surgery are shown in Fig. 1 . The 500-day freedom rate was 57% in the non-mitral valve surgery group and 61% in the mitral valve surgery group. The log-rank test showed that mitral valve surgery was not associated with a conversion rate (P = 0.99).
The results of Cox proportional hazard model are shown in Table 4 . The results of multivariate analysis demonstrated that mitral valve surgery was not associated with long-term prognosis. The only valuable associated with remote prognosis was found to be increased LAD. A further analysis included all patients and was, therefore, performed to detect relationships between LAD and long-term prognosis. The cut-off value for LAD was calculated using the receiver operating characteristic curve. In terms of predictive value, a cut-off LAD of 58.5 mm yielded an area under the curve of 0.701. Patients were divided into groups with LAD < 58.5 mm or ≥ 58.5 mm. Cumulative freedom from AF curves grouped accordingly are shown in Fig. 2 . This Advance Online Publication additional analysis demonstrated that 1000-day freedom from AF rate was 81% in the small LAD group.
Discussion
Several investigators have reported that the Maze procedure represents an effective surgical approach for treating AF. Kosakai et al. reported a defibrillation rate of 84% in patients undergoing the Maze procedure combined with mitral valve surgery.
2) Cox and his colleagues documented 95% freedom from AF in patients undergoing the Maze procedure.
13) The other benefit of the Maze procedure is avoidance of stroke in the remote phase. Bando and his colleagues reported that freedom from stroke after 5 years was 79% in the mitral valve replacement without Maze group, compared with 97% in the mitral valve replacement or mitral valve plasty with Maze groups.
14) The Maze procedure performed simultaneously with mitral valve surgery thus reduces postoperative complications such as thromboembolism and the need for antiarrhythmic agents and anticoagulation. However, the Maze procedure for patients without mitral valve disease remains controversial because of the increased invasiveness and prolonged aorta cross-clamp time required to create additional incisions in the left atrium.
In recent years, the development of radiofrequency ablation devices has simplified the Maze procedure and contributed to reductions in operative time. Several studies have revealed that Maze procedures using radiofrequency devices offer conversion rates comparable to the conventional Maze procedure using a cut-and-saw method. 8, [15] [16] [17] [18] We, therefore, hypothesised that the Maze procedure without mitral valve surgery would be acceptable in terms of operation time and remote freedom from AF when compared to the Maze procedure with mitral valve surgery.
From a technical perspective, some processes are needed to perform the Maze procedure, in addition to isolated non-mitral valvular surgery. First, bicaval cannulae are placed to set up a cardiopulmonary bypass. Caval tapes with tourniquets should be applied to open both atria. Additional exposure is needed to approach the left atrium. Both atrial incisions and ablation lines are made for the Maze procedure. Particularly for the left atrium, the incision required is only for the Maze procedure. These additional processes require an investment of time and effort in the operation. The present study found no differences in operation time or aorta cross-clamp time between the mitral and non-mitral groups. This result suggests that surgery with the Maze procedure may prolong operation time when compared to surgery without the Maze procedure, but the Maze procedure without mitral valve surgery is not prolonged when compared to the Maze procedure with mitral valve surgery. Focusing on the remote results, no differences between groups were seen in freedom from the AF ratio. In consideration of favourable effects due to a sinus conversion, these findings suggest that indications for the Maze procedure should be expanded to include the absence of mitral valve disease. All LAAs were closed by ligation or resection in this study. We performed LAA closure on the expectation of preventing stroke. Left atrial thrombus is reportedly present in 57%-91% of AF patients in the LAA. 19) As a result, LAA closure during surgery for mitral valve replacement is associated with a reduction in the risk of late embolism. 20) Holmes et al. reported that the efficacy of LAA closure was not inferior to that of warfarin therapy. 21) As one of the important aims of the Maze procedure is stroke prevention, LAA closure is an essential technique with the Maze procedure.
As another interesting finding in this study, Cox proportional hazard regression analysis demonstrated that the presence of mitral valve surgery was not an independent predictor of long-term freedom from AF, but LAD was an independent predictor. Larger LAD has been established as a predictor of unsuccessful conversion in the Maze procedure in past studies. 11, 12) Patients in this study included many patients with enlarged LAD. However, favourable prognosis was observed in patients with LAD < 58.5 mm. Although patients with mitral valve disease showed more enlarged LAD, the presence of mitral valve disease was not associated with a success rate of the Maze procedure, whereas LAD was.
Our indication for the Maze procedure specified the enrolment of patients with AF of every description. Hence, some patients who were not expected to be successfully treated AF by the Maze procedure such as patients with extremely enlarged LAD were included in this study. Therefore, the success rate of conversion was relatively low compared with general standards in this study.
We assessed the effects of medications after the Maze procedure, as well. Various medications were used to maintain sinus rhythm after operation. However, it remains unclear what medication is favourable after the Maze procedure. Although data were not shown, we conducted additional analysis to identify the effective medication in the same cohort. The results of the analysis showed that use of amiodarone, beta blocker, digitalis, angiotensin receptor blocker, statin and other antiarrythmic agents were not associated with a successful conversion after an operation. The findings of these analyses revealed that every medication did not contribute to maintain sinus rhythm after the Maze procedure in this study. Therefore, specific medication was not included in the multivariate analysis, in this study.
Several limitations of this study require consideration. Firstly, data were obtained from a small number of patients. In particular, this study is limited study for 11 patients who received the Maze procedure without mitral valve disease. These patients were predominantly few when compared to patients with mitral valve disease underwent the Maze procedure. Hence, we considered that this imbalance of sample size should be accepted. Moreover, all procedures were performed in a single institution, and all patients were Japanese. A large-scale evaluation is needed, and adverse events including stroke must be investigated for the long term. Moreover, rhythm was documented using electrocardiography alone. Neither 24hour electrocardiography monitoring nor continuous home monitoring could be available.
Results of the Maze procedure for AF without mitral valve disease appear acceptable. The Maze procedure could be a beneficial option for these patients to avoid adverse events of atrial fibrillation.
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